Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q34255292)
Watch
English
Molecular pathways: regulation and therapeutic implications of multidrug resistance
scientific article
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PMCID
3359695
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22344233%20AND%20SRC:MED&resulttype=core&format=json
retrieved
23 January 2020
title
Molecular pathways: regulation and therapeutic implications of multidrug resistance
(English)
1 reference
stated in
Europe PubMed Central
PMCID
3359695
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22344233%20AND%20SRC:MED&resulttype=core&format=json
retrieved
23 January 2020
main subject
multiple drug resistance
1 reference
based on heuristic
inferred from title
author
Kevin G. Chen
series ordinal
1
1 reference
stated in
Europe PubMed Central
PMCID
3359695
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22344233%20AND%20SRC:MED&resulttype=core&format=json
retrieved
23 January 2020
Branimir Ivan Sikic
series ordinal
2
object named as
Branimir I Sikic
1 reference
stated in
Europe PubMed Central
PMCID
3359695
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22344233%20AND%20SRC:MED&resulttype=core&format=json
retrieved
23 January 2020
language of work or name
English
0 references
publication date
16 February 2012
1 reference
stated in
Europe PubMed Central
PMCID
3359695
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22344233%20AND%20SRC:MED&resulttype=core&format=json
retrieved
23 January 2020
published in
Clinical Cancer Research
1 reference
stated in
Europe PubMed Central
PMCID
3359695
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22344233%20AND%20SRC:MED&resulttype=core&format=json
retrieved
23 January 2020
volume
18
1 reference
stated in
Europe PubMed Central
PMCID
3359695
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22344233%20AND%20SRC:MED&resulttype=core&format=json
retrieved
23 January 2020
issue
7
1 reference
stated in
Europe PubMed Central
PMCID
3359695
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22344233%20AND%20SRC:MED&resulttype=core&format=json
retrieved
23 January 2020
page(s)
1863-1869
1 reference
stated in
Europe PubMed Central
PMCID
3359695
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22344233%20AND%20SRC:MED&resulttype=core&format=json
retrieved
23 January 2020
cites work
Zosuquidar, a novel modulator of P-glycoprotein, does not improve the outcome of older patients with newly diagnosed acute myeloid leukemia: a randomized, placebo-controlled trial of the Eastern Cooperative Oncology Group 3999
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3359695
retrieved
6 July 2018
Reversal of P-glycoprotein-mediated multidrug resistance by the murine double minute 2 antagonist nutlin-3.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3359695
retrieved
6 July 2018
Involvement of extracellular signal-regulated kinase activation in human osteosarcoma cell resistance to the histone deacetylase inhibitor FK228 [(1S,4S,7Z,10S,16E,21R)-7-ethylidene-4,21-bis(propan-2-yl)-2-oxa-12,13-dithia-5,8,20,23-tetraazabicyclo[
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3359695
retrieved
6 July 2018
Leukemic blast and natural killer cell P-glycoprotein function and inhibition in a clinical trial of zosuquidar infusion in acute myeloid leukemia
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3359695
retrieved
6 July 2018
Acetylation is indispensable for p53 activation
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3359695
retrieved
6 July 2018
MDM2 SNP309 is associated with poor outcome in B-cell chronic lymphocytic leukemia
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3359695
retrieved
6 July 2018
Single-step doxorubicin-selected cancer cells overexpress the ABCG2 drug transporter through epigenetic changes.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3359695
retrieved
6 July 2018
Histone modifications at the ABCG2 promoter following treatment with histone deacetylase inhibitor mirror those in multidrug-resistant cells
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3359695
retrieved
6 July 2018
Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3359695
retrieved
6 July 2018
Restoration of p53 function leads to tumour regression in vivo
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3359695
retrieved
6 July 2018
Characterization of gene rearrangements leading to activation of MDR-1.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3359695
retrieved
6 July 2018
The molecular basis of multidrug resistance in cancer: the early years of P-glycoprotein research
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3359695
retrieved
6 July 2018
Multidrug resistance/P-glycoprotein and breast cancer: review and meta-analysis
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3359695
retrieved
6 July 2018
Genetic and epigenetic modeling of the origins of multidrug-resistant cells in a human sarcoma cell line
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3359695
retrieved
6 July 2018
Up-regulation of MDR1 and induction of doxorubicin resistance by histone deacetylase inhibitor depsipeptide (FK228) and ATRA in acute promyelocytic leukemia cells
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3359695
retrieved
6 July 2018
A phase I trial of liposomal doxorubicin, paclitaxel and valspodar (PSC-833), an inhibitor of multidrug resistance
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3359695
retrieved
6 July 2018
Epigenetic changes to the MDR1 locus in response to chemotherapeutic drugs
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3359695
retrieved
6 July 2018
Cyclosporin A is a broad-spectrum multidrug resistance modulator
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3359695
retrieved
6 July 2018
Brahma links the SWI/SNF chromatin-remodeling complex with MeCP2-dependent transcriptional silencing
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3359695
retrieved
6 July 2018
Targeting the multidrug resistance-1 transporter in AML: molecular regulation and therapeutic strategies
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3359695
retrieved
6 July 2018
CCAAT/enhancer-binding protein beta (nuclear factor for interleukin 6) transactivates the human MDR1 gene by interaction with an inverted CCAAT box in human cancer cells
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3359695
retrieved
6 July 2018
Transcriptional regulation of ABC drug transporters
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3359695
retrieved
6 July 2018
Function and selectivity of bromodomains in anchoring chromatin-modifying complexes to promoter nucleosomes.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3359695
retrieved
6 July 2018
DNA methylation patterns at relapse in adult acute lymphocytic leukemia
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3359695
retrieved
6 July 2018
Increased expression of the breast cancer resistance protein (BCRP) in relapsed or refractory acute myeloid leukemia (AML)
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3359695
retrieved
6 July 2018
Expression and activity of breast cancer resistance protein (BCRP) in de novo and relapsed acute myeloid leukemia.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3359695
retrieved
6 July 2018
Multidrug resistance in cancer: role of ATP-dependent transporters
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3359695
retrieved
6 July 2018
Precipitous release of methyl-CpG binding protein 2 and histone deacetylase 1 from the methylated human multidrug resistance gene (MDR1) on activation
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3359695
retrieved
6 July 2018
Autocrine production of interleukin 6 causes multidrug resistance in breast cancer cells.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3359695
retrieved
6 July 2018
Activation of phospholipase C induces the expression of the multidrug resistance (MDR1) gene through the Raf-MAPK pathway.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3359695
retrieved
6 July 2018
Mutant p53 cooperates with ETS and selectively up-regulates human MDR1 not MRP1.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3359695
retrieved
6 July 2018
Transcriptional repression by p53 through direct binding to a novel DNA element
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3359695
retrieved
6 July 2018
A phase I trial of doxorubicin, paclitaxel, and valspodar (PSC 833), a modulator of multidrug resistance
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3359695
retrieved
6 July 2018
Extensive contribution of the multidrug transporters P-glycoprotein and Mrp1 to basal drug resistance
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3359695
retrieved
6 July 2018
MDR 1 activation is the predominant resistance mechanism selected by vinblastine in MES-SA cells
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3359695
retrieved
6 July 2018
A C/EBP beta isoform recruits the SWI/SNF complex to activate myeloid genes
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3359695
retrieved
6 July 2018
Altered methylation of the human MDR1 promoter is associated with acquired multidrug resistance.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3359695
retrieved
6 July 2018
Demethylation of the human MDR1 5' region accompanies activation of P-glycoprotein expression in a HL60 multidrug resistant subline
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3359695
retrieved
6 July 2018
Transcriptional regulation of the MDR1 gene by histone acetyltransferase and deacetylase is mediated by NF-Y.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3359695
retrieved
6 July 2018
Genetic polymorphism in MDR-1: a tool for examining allelic expression in normal cells, unselected and drug-selected cell lines, and human tumors.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3359695
retrieved
6 July 2018
p53-dependent regulation of MDR1 gene expression causes selective resistance to chemotherapeutic agents
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3359695
retrieved
6 July 2018
Modulation and prevention of multidrug resistance by inhibitors of P-glycoprotein
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3359695
retrieved
6 July 2018
Resistance mechanisms in human sarcoma mutants derived by single-step exposure to paclitaxel (Taxol).
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3359695
retrieved
6 July 2018
Phase I trial of doxorubicin with cyclosporine as a modulator of multidrug resistance.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3359695
retrieved
6 July 2018
A signal transduction pathway for activation of the mdr1 promoter involves the proto-oncogene c-raf kinase
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3359695
retrieved
6 July 2018
Mutation rates and mechanisms of resistance to etoposide determined from fluctuation analysis
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3359695
retrieved
6 July 2018
NF-IL6, a member of the C/EBP family of transcription factors, binds and trans-activates the human MDR1 gene promoter
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3359695
retrieved
6 July 2018
Prevalence of multidrug resistance related to activation of the mdr1 gene in human sarcoma mutants derived by single-step doxorubicin selection.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3359695
retrieved
6 July 2018
Alteration of etoposide pharmacokinetics and pharmacodynamics by cyclosporine in a phase I trial to modulate multidrug resistance
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3359695
retrieved
6 July 2018
Phase I trial of etoposide with cyclosporine as a modulator of multidrug resistance
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3359695
retrieved
6 July 2018
Modulation of activity of the promoter of the human MDR1 gene by Ras and p53.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3359695
retrieved
6 July 2018
A phase I trial of continuous infusion of the multidrug resistance inhibitor zosuquidar with daunorubicin and cytarabine in acute myeloid leukemia.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3359695
retrieved
28 October 2018
Increased MDR1 expression in normal and malignant peripheral blood mononuclear cells obtained from patients receiving depsipeptide (FR901228, FK228, NSC630176).
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3359695
retrieved
28 October 2018
MDR1 promoter hypermethylation in MCF-7 human breast cancer cells: changes in chromatin structure induced by treatment with 5-Aza-cytidine
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3359695
retrieved
28 October 2018
Phase 3 study of the multidrug resistance modulator PSC-833 in previously untreated patients 60 years of age and older with acute myeloid leukemia: Cancer and Leukemia Group B Study 9720.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3359695
retrieved
28 October 2018
Benefit of cyclosporine modulation of drug resistance in patients with poor-risk acute myeloid leukemia: a Southwest Oncology Group study
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3359695
retrieved
28 October 2018
Activity and expression of the multidrug resistance proteins P-glycoprotein, MRP1, MRP2, MRP3 and MRP5 in de novo and relapsed acute myeloid leukemia
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3359695
retrieved
28 October 2018
Comparison of 'sequential' versus 'standard' chemotherapy as re-induction treatment, with or without cyclosporine, in refractory/relapsed acute myeloid leukaemia (AML): results of the UK Medical Research Council AML-R trial
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3359695
retrieved
28 October 2018
Modulation of multidrug resistance: a paradigm for translational clinical research.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3359695
retrieved
28 October 2018
Nuclear expression of YB-1 protein correlates with P-glycoprotein expression in human osteosarcoma.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3359695
retrieved
28 October 2018
Contribution of the murine mdr1a P-glycoprotein to hepatobiliary and intestinal elimination of cationic drugs as measured in mice with an mdr1a gene disruption.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3359695
retrieved
28 October 2018
MDM2Polymorphism, Survival, and Histology in Early-Stage Non–Small-Cell Lung Cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3359695
retrieved
28 October 2018
Deletion of the multidrug resistance protein MRP1 gene in acute myeloid leukemia: the impact on MRP activity
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/22344233
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
MDR1 gene overexpression and altered degree of methylation at the promoter region in bladder cancer during chemotherapeutic treatment
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/22344233
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Hypomethylation status of CpG sites at the promoter region and overexpression of the human MDR1 gene in acute myeloid leukemias
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/22344233
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Nuclear localization and increased levels of transcription factor YB-1 in primary human breast cancers are associated with intrinsic MDR1 gene expression
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/22344233
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Multidrug resistance and stem cells in acute myeloid leukemia
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/22344233
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
ABCB1 modulation does not circumvent drug extrusion from primitive leukemic progenitor cells and may preferentially target residual normal cells in acute myelogenous leukemia
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/22344233
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Identifiers
DOI
10.1158/1078-0432.CCR-11-1590
1 reference
stated in
Europe PubMed Central
PMCID
3359695
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22344233%20AND%20SRC:MED&resulttype=core&format=json
retrieved
23 January 2020
PMCID
3359695
1 reference
stated in
Europe PubMed Central
PMCID
3359695
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22344233%20AND%20SRC:MED&resulttype=core&format=json
retrieved
23 January 2020
PubMed ID
22344233
1 reference
stated in
Europe PubMed Central
PMCID
3359695
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22344233%20AND%20SRC:MED&resulttype=core&format=json
retrieved
23 January 2020
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit